MPD: List measures where strain LP/J is an outlier

List measures where LP/J is an outlier

Click on pulldowns below to see LP/J means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Ackert1:11	Ackert1	DXA	(none)	bone mineral density (BMD) [g/cm²] BMD 25011 6mo 12mo 20mo	inbred	32	both		N=7	2008

Berndt1:21	Berndt1	ventilator	methacholine	airway resistance (as % of baseline, H₂O pressure) [%] pct_res 34221 MCh challenge (mg/mL): 1 3 10 30	inbred	37	both	9-12wks	N=8	2010

Berndt2:61	Berndt2	plethysmography	methacholine	enhanced pause penh 35161 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Hadsell1:3	Hadsell1	colony observation	(none)	number of cross-fostered pups that survived to day 8 (max=10) [n] pups_d8 49403	inbred	31	f	14-18wks	N=10	2012

Harrill1:7	Harrill1	organ weights	isoniazid	liver weight as percentage of body weight [%] pct_liver 39507 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Hawes1:20	Hawes1	ophthalmoscopy	(none)	retinal hypopigmentation [frequency rate] ret_hypopig 26720	inbred w/CC7	40	both	6-7wks	N=10	2008

Johnson1:7	Johnson1	ABR test	(none)	auditory brainstem response (ABR) threshold, 15-72 wk old group, sound pressure level [dB] pip_old 1407 click 8kHz pip 16kHz pip 32kHz pip	inbred	27	both	15-72wks	N=12	2000

Maurer1:66	Maurer1	body weight	atenolol, isoproterenol	fold change in body weight over testing period [ratio] bwchg 33266 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Paigen2:4	Paigen2	lipid profile	high-fat diet	HDL cholesterol (plasma) [mg/dL] HDLC 9904 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Peters4:1	Peters4	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24301 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:9	Peters4	complete blood count	(none)	neutrophil count (NEUT; units per volume x 10³) [n/µL] NEUT 24309 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:13	Peters4	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYMPH 24313 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:17	Peters4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 24317 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:21	Peters4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 24321 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:25	Peters4	complete blood count	(none)	basophil count (BASO; units per volume x 10³) [n/µL] BASO 24325 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:49	Peters4	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctBASO 24349 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:1	Petkova1	immune cell quantification	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24201 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:21	Petkova1	immune cell quantification	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO 24221 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:66	Petkova1	immune cell quantification	(none)	CD8 T cells, effector memory, as percentage of total CD8 T cells [%] CD8_mem_effector 24266 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Tarantino1:5	Tarantino1	open field test	cocaine	ambulatory episodes, 30 min test [n] amb_epi 45916 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino1:14	Tarantino1	open field test	cocaine	percentage of time resting, 30 min test [%] rest 45931 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Threadgill1:9	Threadgill1	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=24h [IU/L] ALT_Rx100_24h 19409	inbred w/CC7	7	m	8-17wks	N=3	2005

Threadgill1:10	Threadgill1	metabolic panel	acetaminophen	aspartate transaminase (serum AST) [IU/L] AST 19410 dose (mg/kg): control 100 200 300	inbred w/CC7	37	m	8-17wks	N=2	2005

Tordoff1:22	Tordoff1	bottle choice test	(none)	preference for NH4Cl (ammonium chloride) solutions [%] NH4Cl_pref 6122 concentration (mM): 10 30 100 300	inbred	28	m	4-12wks	N=11	2001

Tordoff3:8	Tordoff3	bottle choice test	(none)	preference for CaCl2 (calcium chloride) solutions [%] CaCl2_pref 10308 concentration (mM): 7.5 25 75	inbred w/CC7	40	both	9-11wks	N=10	2002

Wiltshire3:1	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity ACTH 38101 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:4	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex APOD, relative fluorescence intensity APOD 38104 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:7	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex BAG1, relative fluorescence intensity BAG1 38107 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:10	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex BDNF, relative fluorescence intensity BDNF 38110 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:13	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex CREB1 (CREB), relative fluorescence intensity CREB1 38113 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:16	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex FOS (c-fos), relative fluorescence intensity FOS 38116 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:19	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex FUT9, relative fluorescence intensity FUT9 38119 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:22	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GAD1 (GAD67), relative fluorescence intensity GAD1 38122 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:31	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GHRL, relative fluorescence intensity GHRL 38131 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:34	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GIRK3 (KCNJ9), relative fluorescence intensity GIRK3 38134 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:37	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GLO1, relative fluorescence intensity GLO1 38137 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:43	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GRIN1 (NMDA1), relative fluorescence intensity GRIN1 38143 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:46	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GSK3B, relative fluorescence intensity GSK3B 38146 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:49	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GSR, relative fluorescence intensity GSR 38149 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:52	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex HDAC5, relative fluorescence intensity HDAC5 38152 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:58	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex NPY, relative fluorescence intensity NPY 38158 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:61	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex P2RX7 (P2X7), relative fluorescence intensity P2RX7 38161 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:64	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PAQR8, relative fluorescence intensity PAQR8 38164 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:67	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PPP1R1B, relative fluorescence intensity PPP1R1B 38167 control fluoxetine	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:70	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PTH, relative fluorescence intensity PTH 38170 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:73	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex S100B, relative fluorescence intensity S100B 38173 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:76	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SCG5 (SGNE), relative fluorescence intensity SCG5 38176 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:79	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SLC6A2 (NET), relative fluorescence intensity SLC6A2 38179 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:82	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SLC6A4 (SERT), relative fluorescence intensity SLC6A4 38182 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:85	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SST, relative fluorescence intensity SST 38185 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:88	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex TNF (TNFa), relative fluorescence intensity TNF 38188 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:91	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex VEGFA (VEGF), relative fluorescence intensity VEGFA 38191 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Yuan3:36	Yuan3	metabolic panel	(none)	phosphorus (serum P) [mg/dL] Phos 24436 6mo 12mo 18mo	inbred	32	both		N=7	2008

Zheng1:1	Zheng1	tympanometry	(none)	tympanic membrane compliance, right ear [mL] Rcompliance 29801	inbred	61	both	5-68wks	N=4	2008

Zheng1:5	Zheng1	tympanometry	(none)	tympanic membrane compliance, left ear [mL] Lcompliance 29805	inbred	61	both	5-68wks	N=4	2008

List measures where LP/J is an outlier

Filter Table Results